ESR1 and triple-negative breast carcinoma: Triple negative breast cancer (TNBC) which lack of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor type 2 (HER2) has the poorest survival outcome due to its aggressiveness and lack of therapeutic target (1, 2).